Sildenafil (Generic) Dose Adjustments for East Asian Patients
Evidence-based guide to sildenafil 20-100 mg dosing in East Asian populations, covering CYP3A4/CYP2C9 pharmacogenomics, body-weight considerations, and clinical trial subgroup data.
5 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.

Showing 5 of 5 clinical reviews.
Evidence-based guide to sildenafil 20-100 mg dosing in East Asian populations, covering CYP3A4/CYP2C9 pharmacogenomics, body-weight considerations, and clinical trial subgroup data.
Evidence-based guide to sildenafil 20-100 mg dosing in Hispanic and Latino patients, covering CYP2C9/3A4 pharmacogenomics, diabetes-related considerations, and clinical recommendations.
How CYP2C19 poor-metabolizer status, lower BMI thresholds, and ethnicity-stratified pharmacokinetic data change sildenafil dosing and safety decisions for East Asian patients.
Evidence-based review of sildenafil pharmacogenomic differences in East Asian populations, including CYP3A4/CYP2C9 metabolism variations, lower effective doses, and clinical trial subgroup data.
Evidence-based review of how sildenafil 20-100 mg safety and pharmacogenomics differ in South Asian populations, including dosing adjustments, cardiovascular considerations, and CYP enzyme polymorphism data.